Abstract:Objective To investigate the differential expression of mitochondrial microRNAs (mitomiRs) in tongue squamous cell carcinoma (TSCC) and to screen out mitomiRs related to chemotherapy resistance. Methods Mitochon⁃ drial, cytoplasmic, and total cellular RNAs were extracted from the squamous cell carcinoma cell line CAL⁃27 and the cisplatin⁃resistant cell line CAL⁃27⁃re. High⁃throughput miRNA microarrays were used to screen for differentially ex⁃ pressed mitomiRs between the drug⁃resistant and parental cells. The upregulated mitomiRs in the CAL⁃27 and CAL⁃27⁃ re cells and in samples from chemoresistant and chemosensitive tongue squamous cell carcinoma patients were verified by qRT⁃PCR. Results The microarray detected 263 miRNAs in 6 components of the mitochondrial, cytoplasmic and total cellular RNAs from the CAL⁃27 and CAL⁃27⁃re cells, including 57 mitomiRs and 134 cytoplasmic microRNAs (cy⁃ tomiRs). Compared with the total miRNAs, 35 mitomiRs were upregulated in the CAL⁃ 27⁃re cells, and 31 mitomiRs were upregulated in the CAL⁃27 cells (≥ 1.5⁃fold). Further comparative analysis of mitomiRs that were differentially ex⁃ pressed between the parental and drug⁃resistant cells identified 11 upregulated mitomiRs (miR⁃2392, miR⁃4462, miR⁃ 1290, miR⁃4449, miR⁃1268a, miR⁃1246, and miR⁃371a⁃5p, miR⁃3934⁃5p, miR⁃4271, miR⁃513p, and miR⁃664b⁃3p) and 5 downregulated mitomiRs (miR⁃188⁃5p, miR⁃1973, miR ⁃3653, miR⁃4499, and miR⁃5787); the expression levels of the other 41 mitomiRs were almost identical in both cell lines. The qRT⁃PCR results were consistent with the miRNA microarray results. The 11 upregulated mitomiRs that were validated between the CAL⁃27 and CAL⁃27⁃re cells included miR⁃1268a, miR⁃2392, miR⁃4462, and miR⁃1290. Additionally, 5 mitomiRs, including miR⁃4449, were upregulated in the clinical chemotherapy⁃resistant tongue squamous cell carcinoma samples. Conclusion Differentially expressed mit⁃ omiRs were found between cisplatin⁃resistant and cisplatin⁃sensitive tongue squamous cell carcinoma cells. mitomiRs with high expression levels (miR⁃2392, miR⁃4462, miR⁃1290, miR⁃4449 and miR⁃1268a) may play important roles in the drug resistance of tongue squamous cell carcinoma.

Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation.

Screening and Identification of Mitochondrial Mirnas Related to Chemotherapy Resistance in Tongue Squamous Cell Carcinoma

Mitochondrial miRNA Determines Chemoresistance by Reprogramming Metabolism and Regulating Mitochondrial Transcription.

MicroRNAs Contribute to the Chemoresistance of Cisplatin in Tongue Squamous Cell Carcinoma Lines.

Mitochondrial Fission Determines Cisplatin Sensitivity in Tongue Squamous Cell Carcinoma Through the Brca1-Mir-593-5p-Mff Axis

Long Noncoding RNA MPRL Promotes Mitochondrial Fission and Cisplatin Chemosensitivity via Disruption of Pre-miRNA Processing

The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1

Abstract A13: The microRNA-200 family overcomes cisplatin resistance by targeting ceramide glycosylation

miR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4

Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells

The role of microRNA in cisplatin resistance or sensitivity

miR-185-5p May Modulate the Chemosensitivity of LUSC to Cisplatin via Targeting PCDHA11: Multi-omics Analysis and Experimental Validation

Mir-483-5p Determines Mitochondrial Fission and Cisplatin Sensitivity in Tongue Squamous Cell Carcinoma by Targeting FIS1.

Attenuation of deregulated miR-369-3p expression sensitizes non-small cell lung cancer cells to cisplatin via modulation of the nucleotide sugar transporter SLC35F5

miR-185-5p rewires cisplatin resistance by restoring miR- 203a-3p expression via downregulation of SOX9

A tumor-promotional molecular axis CircMAPKBP1/miR-17-3p/TGFβ2 activates autophagy pathway to drive tongue squamous cell carcinoma cisplatin chemoresistance

Microrna-137 Inhibits Tumor Growth And Sensitizes Chemosensitivity To Paclitaxel And Cisplatin In Lung Cancer

Micro1278 Leads to Tumor Growth Arrest, Enhanced Sensitivity to Oxaliplatin and Vitamin D and Inhibits Metastasis via KIF5B, CYP24A1, and BTG2, Respectively

Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis

MicroRNA-218 Promotes Cisplatin Resistance in Oral Cancer Via the PPP2R5A/Wnt Signaling Pathway